0003-0050Level 3
Cobenfy (xanomeline and trospium chloride)
**Product type:** Human Prescription Drug
**Active ingredient:** TROSPIUM CHLORIDE; XANOMELINE
**Strength:** 20; 50 mg/1; mg/1
**Dosage form:** Capsule, Coated Pellets
**Route:** Oral
**Labeler:** E.R. Squibb & Sons, L.L.C.
**Marketing category:** NDA (NDA216158)
**Pharmacologic class:** Cholinergic Muscarinic Agonist [EPC], Cholinergic Muscarinic Agonists [MoA], Cholinergic Muscarinic Antagonist [EPC], Cholinergic Muscarinic Antagonists [MoA], Cytochrome P450 3A4 Inhibitors [MoA], P-Glycoprotein Inhibitors [MoA]
GET
/api/v1/systems/ndc_fda/nodes/0003-0050Hierarchy Explorer
Loading...
Cross-system equivalences0
No cross-system equivalences mapped for this node.